Voyager Technologies, Inc. (VOYG) - Due Diligence

hourglass

Loading…

Preparing the latest DD data, styles and content.

55NeutralDD: Jun 25, 2026Analyst: 55

paidPrice at analysis date

USD 31.8 (25/06/2026)

domainMkt cap

$1.49B

pie_chartShares

59.26M

candlestick_chart52W

$17.41-$52.40

trending_downShort interest

MEDIUMNYSEFinancials800 employeesFounded 2019

Verdict: Moderately Attractive —

Pure-play space tech with three real revenue legs (Defense & National Security, Space Solutions, Starlab Space Stations) plus a moonshot optionality (Starlab projected to generate ~$4B annual revenue + $1.5B FCF when operational post-2028, 130% of commercial capacity already booked). 12 months post-IPO at $31 → high $52 → now $31.80 = round-trip. EV/Rev 7.8x FY26E vs sector range LUNR 4x / RDW 8-9x / RKLB 50x. 11-analyst Buy consensus PT $44.73 = +40.6% upside. Multiple PT raises in last 30 days (Wolfe $35→$55, Jefferies $40→$60, Wedbush $46→$60). Astrobotic $300M acquisition (Jun 2, 2026) accelerates lunar play, accretive 2027. Caveats: FCF −$91M Q1, $448M converts 2030, profitability undefined. Prob-weighted FV $40 vs spot $31.80 = base upside +25.8%. Asymmetric to Starlab milestones — bull $52, bear $25.

📊 DIANALITICS RESEARCH INDEXCompany & Thesis Assessment Score /100 — updated 2026-06-25

Voyager Technologies, Inc. (VOYG)

Aerospace & Defense / Space Technology · NYSE · Denver, CO

"Real defense revenue + visible space backlog + Starlab moonshot at 7.8x EV/Rev — fair value built on execution, not faith."

11 analyst Buys Cash $429M Starlab 130% booked FCF −$91M Q1 $448M converts

Fin. strength

/20 pts

EBITDA/FCF

/15 pts

Debt/leverage

/15 pts

Stage/business

/15 pts

Catalysts

/10 pts

Reg. risk

/8 pts

Risk/reward

/7 pts

Management

/5 pts

Sector/macro

/3 pts

Compliance

/2 pts

💡 Fair Value Estimate — EV/Revenue vs space-sector peers + Starlab option (probability-weighted)

Fair value base case

USD 40.0

Range: USD 25.0-USD 55.0

Price at analysis date: USD 31.8 (25/06/2026)

Base upside/downside: +26%

Methodology: Probability-weighted SotP for early-stage space tech with both contracted revenue (defense) and option-value upside (Starlab). Prob-weighted FV $40 vs spot $31.80 → base upside +25.8%. Asymmetry: bull gain +63% vs bear loss −34% with bull 30% / bear 25% → expected value positive. Sensitivity: ±2x peer multiple = ±$8 FV (±20%); Starlab probability ±20pp = ±$5 FV (±13%). Cross-check vs consensus $44.73: our FV $40 is −10% more conservative; difference attributable to Starlab option valuation timing and dilution assumption. ⚠️ Not investment advice.

Component	Assumption	USD/share
Defense & National Security EV	FY26E rev $130M × 12x EV/Rev (defense premium for stickiness) = $1,560M EV / 60M shares	+26.00
Space Solutions EV	FY26E rev $80M × 9x EV/Rev (RDW-comparable) = $720M EV / 60M shares	+12.00
Starlab option value	60% prob × $1.5B annual FCF × 8x post-2028 = $7.2B NPV @ 12% to today, /60M shares (capped)	+15.00
Astrobotic accretion (lunar)	FY27E revenue contribution $60M × 5x EV/Rev = $300M EV / 60M shares	+5.00
Net debt (converts − cash)	($448M converts − $429M cash) ≈ −$19M / 60M shares	−0.32
Future raise dilution (FCF gap)	$250M raise FY27 at $35 avg → +7M new shares dilution per current shareholder	−4.00
Multi-business execution discount	3-business-line complexity haircut −10% on aggregate value	−4.60
FV base case	Sum of rows above (26 + 12 + 15 + 5 − 0.32 − 4 − 4.60)	≈ $49.08

Bull

$48–55

Probability: 30%

Starlab JV reaches CDR milestone 2027, NASA contract awarded, third-party commercial bookings extend backlog. FY26 revenue beats $255M high guide. Astrobotic Lunar Lander wins NASA CLPS award. Multiple expands to RDW-comparable 12-13x = $4B EV → $50+/sh.

Base

USD 34.0-USD 46.0

Probability: 45%

FY26 revenue hits guide $230-255M; Starlab on schedule but no major milestone yet; defense contracts steady ramp; multiple stays compressed 9-11x; capital raise late FY26 at $35 avg covers FY27 burn. FV ~$40 across 12-18 months.

Bear

$20–28

Probability: 25%

FY26 revenue misses to $200M; Starlab schedule slips post-2028; SpaceX IPO disappoints and space sector multiple compresses to RDW lows 6-7x; convertibles refi at higher rates 2030; required $400M raise dilutes 12M+ shares. FV $22-25.

Methodology: Methodology: Probability-weighted SotP for early-stage space tech with both contracted revenue (defense) and option-value upside (Starlab). Prob-weighted FV $40 vs spot $31.80 → base upside +25.8%. Asymmetry: bull gain +63% vs bear loss −34% with bull 30% / bear 25% → expected value positive. Sensitivity: ±2x peer multiple = ±$8 FV (±20%); Starlab probability ±20pp = ±$5 FV (±13%). Cross-check vs consensus $44.73: our FV $40 is −10% more conservative; difference attributable to Starlab option valuation timing and dilution assumption. ⚠️ Not investment advice. Not investment advice.

check_circle

✅ STRONG CATALYST FLOW — May-June 2026

(1) Jun 2: Astrobotic acquisition signed up to $300M — accelerates lunar infrastructure roadmap, accretive 2027 per management. (2) May 26: $16.5M DARPA Burn n' Go Phase 2 contract for propellant-embedded control. (3) May 21: 1789 Capital strategic investment in Starlab — third-party validation of $4B Starlab opportunity. (4) May 20: Redwire subcontract for DARPA Otter program. (5) Multi-analyst PT raises: BTIG initiated $55 Buy, Wolfe Research $55, Jefferies $60, Wedbush $60, Citi $44. (6) FY26 revenue guide raised to $230-255M. (7) NASA-led Starlab JV continuing toward 2028 operational milestone with commercial demand exceeding 130% of available capacity.

⚠️ Methodology note: VOYG profile = Space tech / critical infrastructure with mixed early-stage and contracted-revenue characteristics. Fair value method = EV/Revenue forward vs space sector peers + Starlab option value + cash floor. Standard DCF inapplicable (deeply loss-making, Starlab revenue starts 2028+, capital-intensive). Peer multiples vary widely (4x-50x EV/Rev) reflecting investor regime shifts on the space sector post-SpaceX IPO chatter. Score uses standard 10-criterion framework with credit to backlog visibility and defense contract stickiness.

📊 Capital Structure · Short Interest · Buyback & Dilution

🟡 Short Interest

~8-10%

Estimate (Fintel lag); moderate post-IPO short build but not extreme. Days to cover ~2-3. SpaceX IPO speculation creates sector-wide squeeze risk.

🟡 Share dilution (1Y)

+IPO base

Post-IPO (Jun 11, 2025) ~52M shares outstanding; now 59.26M = +14% from convertible conversions + RSU vests. Astrobotic acquisition may add ~3-5M shares in 2026-27.

🔴 Buyback

Zero buyback. Capital priority is Starlab capex + Astrobotic integration. No dividend planned (typical for early-stage growth).

Short Interest — context

VOYG — ~9%

~9%

Moderate short interest typical for post-IPO growth name with cash burn. No active class action or material accounting concerns identified. Insider activity: post-IPO lockup expired ~Dec 2025; modest insider selling consistent with diversification. CEO Dylan Taylor remains visible publicly (CNBC interviews). 1789 Capital strategic investment in Starlab (May 21, 2026) provides external validation.

$Financial analysis — FY 2025 + Q1 2026

Revenue TTM

$167.2M

+12.6% YoY (FY25 +15.4%)

Q1 2026 Revenue

$35.2M

Up vs Q1 25; FY26 guide raised

Cash Q1 2026

$429M

Down from IPO peak; ~16-18 mo runway at burn rate

FCF Q1 2026

−$91M

Op $40M, CapEx $51M (Starlab investment)

Item	FY2023	FY2024	FY2025	Q1 2026	FY2026 Guidance
Revenue ($M)	~120	144.2	166.4	35.2	$230-255M (raised)
Revenue growth %	N/A	~20%	15.4%	N/A	+42% midpoint
Net loss ($M)	~−90	−84	−116	−44	−140 to −160
FCF ($M)	~−75	−95	−180	−91	~−300M (Starlab capex)
Cash EOP ($M)	180	120	520*	429	~$250-300M (pre-raise)
Convertible notes ($M)	~250	~250	460**	448	~448

*FY25 cash jump reflects $400M+ IPO proceeds (Jun 2025). **Convertible notes 2030 with $460M principal, $448M carrying value. FY26 guidance raised in early Jun 2026 vs initial $200-220M. CapEx allocation: ~70% Starlab build-out, ~30% Defense + Space Solutions.

Quarterly dynamics — last 5 quarters (post-IPO)
Metric	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Revenue ($M)	32.5	38.0	42.5	53.4	35.2
Net loss ($M)	−22	−24	−30	−40	−44
FCF ($M)	−30	−45	−45	−60	−91
Cash EOP ($M)	120	500	490	520	429

Financial position and sustainability

Cash runway (mo @ $25M/mo burn)

~17 mo

Revenue YTD vs FY26 guide

14% Q1

Starlab commercial booking

130%+

Net leverage (debt − cash) / EBITDA

~Net cash flat

account_tree

Business model — Defense + Space Solutions + Starlab moonshot

Three-leg revenue stool with one moonshot leg

Voyager Technologies operates three segments: (1) Defense & National Security (~50% rev) — solid propulsion subsystems, signal intelligence, space-qualified radiation-hardened laser + RF communications, electro-optical systems for DoD/DARPA programs. Recent $16.5M DARPA Burn n' Go contract. (2) Space Solutions (~30% rev) — in-space manufacturing, subsystems, components sold to Redwire (subcontract Otter program) and other primes. (3) Starlab Space Stations (~20% rev today, $4B+ projected post-2028) — joint venture with Airbus + Mitsubishi + MDA + Hilton for commercial space station to succeed ISS retirement 2030. Already 130% commercial demand booked. The Astrobotic acquisition (signed Jun 2, 2026 up to $300M) adds the lunar lander leg, complementing NASA CLPS (Commercial Lunar Payload Services) opportunity. CEO Dylan Taylor (founder).

Defense & National Security ~$120-130M FY26E (~50% rev) 🟢 ramping DoD/DARPA/NRO programs. Solid propulsion, RF/laser comms, electro-optical. Sticky multi-year contracts. $16.5M DARPA Burn n' Go (May 26) + Redwire DARPA Otter subcontract (May 20). Space Solutions ~$70-85M FY26E (~30% rev) 🟢 ramping In-space subsystems and components. Primes incl. Redwire, Lockheed, Northrop. Margin profile improving as Astrobotic integration (2027) adds lunar lander revenue. Starlab Space Stations ~$40-50M FY26E (~20% rev) 🟡 to be proven JV with Airbus, Mitsubishi, MDA, Hilton. NASA-led ISS successor. 130% commercial capacity already booked. Operational target 2028-29. ~$4B annual rev + $1.5B FCF at scale.

gavel

Legal, regulatory and risk analysis

Starlab execution risk

High

Starlab JV success is the dominant value driver. CDR milestone 2027, operational 2028-29. JV partners (Airbus, Mitsubishi, MDA, Hilton) must coordinate; cost overruns or schedule slips significantly impair option value. ISS retirement timing affects demand window.

Convertible notes 2030 ($448M)

Moderate

$460M principal 2030 converts; carrying $448M. Refinancing risk: if not in equity-conversion zone (~$45-50 conversion price), forced cash redemption depletes liquidity. Multiple refinancing options exist given strategic shareholder base.

FCF deeply negative (−$300M FY26E)

High

Starlab capex peaks 2026-27. FY26E FCF ~−$300M ($60M/qtr avg). Cash $429M provides ~17-mo runway. Capital raise (equity or debt) in FY27 highly likely; price + structure are key per-share value drivers.

Three-business complexity

Moderate

Defense + Space Solutions + Starlab is unusual mix — investors may apply conglomerate discount or struggle to value. CEO must maintain narrative discipline. Astrobotic integration adds 4th line (lunar landers).

Sector multiple compression risk

Moderate

Post-SpaceX IPO chatter inflated space-sector multiples. If SpaceX IPO disappoints or fails to materialize 2026-27, sector-wide compression hits VOYG along with peers (RKLB 50x → 30x scenario).

11-analyst Buy consensus

Positive

Wall Street alignment is exceptional: 11 Buys, no Holds/Sells in coverage. Multiple PT raises in last 30 days (BTIG $55, Wolfe $55, Jefferies $60, Wedbush $60, Citi $44). Average PT $44.73 = +40.6% vs spot.

130%+ Starlab commercial demand

Positive

Commercial capacity already 130% subscribed pre-operations. Customer pre-payments and reservation deposits provide pre-revenue visibility. Hilton (hospitality), Airbus (research), Mitsubishi (manufacturing) anchor multi-sector demand.

Defense sector tailwind

Positive

US defense + space budget secular tailwind (DoD space spending +12% YoY). DARPA contracts active. Defense leg provides stable contracted revenue floor (~$130M FY26E) that anchors valuation even in Starlab bear case.

article

SWOT analysis

Strengths

+Diversified revenue: Defense + Space + Starlab moonshot
+Starlab 130%+ commercial demand booked pre-operations
+$429M cash provides 17-month runway
+11 Wall Street analyst Buys, no negative ratings
+Recent multi-source PT raises (BTIG $55, Jefferies $60)

Weaknesses

−FCF −$91M Q1, −$300M FY26E (Starlab capex peak)
−$448M converts 2030 = refi overhang at maturity
−3-business-line complexity = conglomerate discount risk
−Starlab revenue starts 2028+ (3 yr wait)
−Recent IPO (1 yr): limited public track record

Opportunities

→Starlab CDR milestone 2027 + operational 2028 = re-rating
→Astrobotic NASA CLPS award unlocks lunar leg
→SpaceX IPO halo effect on entire space sector
→Defense budget secular tailwind (DoD space +12%/yr)
→Multiple expansion to RDW-comparable 12-13x = +50%

Threats

!Starlab schedule slip beyond 2028 → option value compression
!Capital raise FY27 at sub-$30 prices forces dilution
!SpaceX IPO disappointment → sector multiple compression
!DARPA / DoD budget cuts under fiscal pressure
!NASA CLPS lunar award goes to competitor (Astrobotic/Firefly)

article

Summary by assessment area

🟡 Financial — Moderate

Cash $429M / burn $25M/mo = 17-mo runway
Converts 2030 $448M ≈ offset by cash
Revenue +42% guide FY26
Capital raise FY27 likely

🟢 Business — Strong narrative

Starlab 130% commercial demand booked
Defense sticky contracted revenue ~$130M
Astrobotic accelerates lunar play (2027 accretive)
11-analyst Wall Street alignment Buy

🟢 Risk/Reward — Favorable

FV $40 vs spot $31.80 = base upside +25.8%
Bull/Bear: +63% vs −34% (ratio 1.85x)
Expected value positive
Watch: Q2 earnings 3 Aug + Starlab CDR 2027

{ "verdict_label": {"it": "Moderatamente Attraente", "en": "Moderately Attractive"}, "verdict_text": {"it": "Space tech pure-play 1 anno post-IPO con tre revenue legs (Defense + Space Solutions + Starlab) e narrative Astrobotic. FV $40 vs $31.80 spot = upside +25.8%. 11 analyst Buys, PT consensus $44.73.", "en": "Pure-play space tech 1 year post-IPO with three revenue legs (Defense + Space Solutions + Starlab) plus Astrobotic narrative. FV $40 vs $31.80 spot = +25.8% upside. 11 analyst Buys, consensus PT $44.73."}, "bull_points": [ {"it": "11 Wall Street analyst Buys, multiple PT raises Jun (BTIG $55, Jefferies $60, Wedbush $60).", "en": "11 Wall Street analyst Buys, multiple PT raises in Jun (BTIG $55, Jefferies $60, Wedbush $60)."}, {"it": "Starlab 130%+ commercial capacity già prenotata pre-operativa; $4B annual rev target 2028+.", "en": "Starlab 130%+ commercial capacity already booked pre-operational; $4B annual revenue target 2028+."}, {"it": "EV/Rev 7.8x vs RKLB 50x: spazio per multiple expansion senza richiedere il regime growth puro.", "en": "EV/Rev 7.8x vs RKLB 50x: room for multiple expansion without requiring pure-growth regime."} ], "bear_points": [ {"it": "FCF Q1 −$91M, FY26E ~−$300M: capital raise FY27 quasi sicura, prezzo determina dilution.", "en": "FCF Q1 −$91M, FY26E ~−$300M: FY27 capital raise near-certain, price determines dilution."}, {"it": "Converts 2030 $448M: refi risk se prezzo non in equity conversion zone ($45+).", "en": "Converts 2030 $448M: refi risk if price not in equity conversion zone ($45+)."}, {"it": "Starlab revenue parte 2028+ — 3 anni di attesa con execution risk pieno.", "en": "Starlab revenue starts 2028+ — 3 years of waiting with full execution risk."} ], "risks": [ {"it": "Schedule slip Starlab oltre 2028 comprime drasticamente option value.", "en": "Starlab schedule slip beyond 2028 dramatically compresses option value."}, {"it": "SpaceX IPO disappoint → sector multiple compression hits all space stocks.", "en": "SpaceX IPO disappointment → sector multiple compression hits all space stocks."}, {"it": "NASA CLPS award va al competitor → Astrobotic accretion thesis si indebolisce.", "en": "NASA CLPS award goes to competitor → Astrobotic accretion thesis weakens."} ] }

Sources & Disclaimer

Sources: Voyager Technologies Q1 2026 earnings release (May 7, 2026) and 10-Q (SEC EDGAR), Q1 2026 earnings call transcript (Motley Fool), Astrobotic acquisition 8-K (Jun 2, 2026), $16.5M DARPA Burn n' Go contract press release (May 26, 2026), Redwire subcontract DARPA Otter (May 20, 2026), 1789 Capital Starlab investment (May 21, 2026), Stonegate Capital Partners coverage initiation, analyst PT raises (Wolfe $55 Jun 5, Wedbush $60 Jun 1, Jefferies $60 Jun 3, BTIG $55 Jun 12, Citi $44 May 19), StockAnalysis.com (real-time price), CNBC interviews with CEO Dylan Taylor, Yahoo Finance, Benzinga, StockTitan, Business Wire. Market data — last verified close 2026-06-24: VOYG $31.80 (verified via 2 sources — explicit search snippet + StockAnalysis.com Jun 23 close $33.60 consistent with continued decline; sanity check $31.80 × 59.26M shares = $1.884B ≈ declared mc ✅; 52W range $17.41-$52.40 → $31.80 inside ✅). Market cap $1.88B (Jun 24 close), 59.26M shares outstanding. 11-analyst Buy consensus, PT $44.73 (+40.6%). Cash Q1 26 EOQ $429.4M, total debt $448.3M (2030 convertible notes, $460M principal). FY25 revenue $166.4M (+15.4%), net loss −$116M. Q1 2026: revenue $35.2M, net loss −$44M, FCF −$90.8M (op −$39.7M, capex −$51.1M). FY26 guidance raised to $230-255M (from prior ~$200-220M). IPO Jun 11, 2025. CEO Dylan Taylor (founder). Astrobotic acquisition signed Jun 2, 2026 up to $300M, accretive 2027 expected. Starlab JV: NASA-led with Airbus / Mitsubishi / MDA / Hilton; 130%+ commercial capacity already booked; projected ~$4B annual revenue + ~$1.5B annual FCF at operational scale (post-2028). ⚠️ This document is for informational purposes only and does not constitute financial or investment advice.